Effects of Compound Probiotics and Aflatoxin-degradation Enzyme on Alleviating Aflatoxin-induced Cytotoxicity in Chicken Embryo Primary Intestinal Epithelium, Liver and Kidney Cells
Overview
Authors
Affiliations
Aflatoxin B (AFB) is one of the most dangerous mycotoxins for humans and animals. This study aimed to investigate the effects of compound probiotics (CP), CP supernatant (CPS), AFB-degradation enzyme (ADE) on chicken embryo primary intestinal epithelium, liver and kidney cell viabilities, and to determine the functions of CP + ADE (CPADE) or CPS + ADE (CPSADE) for alleviating cytotoxicity induced by AFB. The results showed that AFB decreased cell viabilities in dose-dependent and time-dependent manners. The optimal AFB concentrations and reactive time for establishing cell damage models were 200 µg/L AFB and 12 h for intestinal epithelium cells, 40 µg/L and 12 h for liver and kidney cells. Cell viabilities reached 231.58% (p < 0.05) for intestinal epithelium cells with CP addition, 105.29% and 115.84% (p < 0.05) for kidney and liver cells with CPS additions. The further results showed that intestinal epithelium, liver and kidney cell viabilities were significantly decreased to 87.12%, 88.7% and 84.19% (p < 0.05) when the cells were exposed to AFB; however, they were increased to 93.49% by CPADE addition, 102.33% and 94.71% by CPSADE additions (p < 0.05). The relative mRNA abundances of IL-6, IL-8, TNF-α, iNOS, NF-κB, NOD1 (except liver cell) and TLR2 in three kinds of primary cells were significantly down-regulated by CPADE or CPSADE addition, compared with single AFB group (p < 0.05), indicating that CPADE or CPSADE addition could alleviate cell cytotoxicity and inflammation induced by AFB exposure through suppressing the activations of NF-κB, iNOS, NOD1 and TLR2 pathways.
Choi H, Garavito-Duarte Y, Gormley A, Kim S Toxins (Basel). 2025; 17(1).
PMID: 39852996 PMC: 11768593. DOI: 10.3390/toxins17010043.
Therapeutic Effect of Natural Products and Dietary Supplements on Aflatoxin-Induced Nephropathy.
Ofori-Attah E, Hashimoto M, Oki M, Kadowaki D Int J Mol Sci. 2024; 25(5).
PMID: 38474096 PMC: 10932067. DOI: 10.3390/ijms25052849.
Feng H, Yao L, Zeng Z, Jiang L, Shang Y, Wang H J Virol. 2023; 97(5):e0032423.
PMID: 37042750 PMC: 10231145. DOI: 10.1128/jvi.00324-23.
He X, Zeng Z, Wu P, Jiang W, Liu Y, Jiang J Front Immunol. 2022; 13:1027064.
PMID: 36330527 PMC: 9623247. DOI: 10.3389/fimmu.2022.1027064.
Guo H, Wang P, Liu C, Zhou T, Chang J, Yin Q Toxins (Basel). 2022; 14(10).
PMID: 36287934 PMC: 9609892. DOI: 10.3390/toxins14100665.